PHAT · Phathom Pharmaceuticals, Inc.
$11.64
-0.02 (-0.17%)
At close · Jul 29
Earnings today
Market Cap
$928.36M
Shares
79.76M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding PHAT
160 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Invesco Global Fund | — | 2,342,451 | $26,235,451 | 0.29% | Long | 2026-04-30 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 1,961,598 | $21,793,354 | 0.00% | Long | 2026-03-31 | |
| iShares Russell 2000 ETF | — | 1,119,747 | $12,440,389 | 0.02% | Long | 2026-03-31 | |
| Strategic Advisers U.S. Total Stock Fund | — | 966,287 | $9,266,692 | 0.01% | Long | 2026-05-31 | |
| Nomura Small Cap Growth Fund | — | 819,324 | $9,102,690 | 0.92% | Long | 2026-03-31 | |
| Wasatch Micro Cap Fund | — | 806,558 | $8,960,859 | 1.60% | Long | 2026-03-31 | |
| Franklin Small Cap Growth Fund | — | 565,898 | $6,338,058 | 0.26% | Long | 2026-04-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 558,872 | $6,209,068 | 0.01% | Long | 2026-03-31 | |
| Wasatch Ultra Growth Fund | — | 494,719 | $5,496,328 | 1.37% | Long | 2026-03-31 | |
| Franklin Biotechnology Discovery Fund | — | 487,012 | $5,454,534 | 0.53% | Long | 2026-04-30 | |
| Fidelity Small Cap Index Fund | — | 457,299 | $5,121,749 | 0.02% | Long | 2026-04-30 | |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF | — | 398,901 | $4,431,790 | 1.44% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 356,945 | $3,965,659 | 0.05% | Long | 2026-03-31 | |
| Invesco V.I. Global Fund | — | 345,650 | $3,840,172 | 0.32% | Long | 2026-03-31 | |
| JNL/Invesco Global Growth Fund | — | 337,376 | $3,748,247 | 0.32% | Long | 2026-03-31 | |
| iShares Russell 2000 Value ETF | — | 289,335 | $3,214,512 | 0.03% | Long | 2026-03-31 | |
| Invesco Global Equity Portfolio | — | 283,184 | $3,146,174 | 0.32% | Long | 2026-03-31 | |
| Simplify Propel Opportunities ETF | — | 262,386 | $2,915,108 | 4.20% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 255,237 | $2,447,723 | 0.01% | Long | 2026-05-31 | |
| AMG GW&K Small Cap Growth Fund | — | 215,757 | $2,416,478 | 1.16% | Long | 2026-04-30 | |
| Invesco Dorsey Wright SmallCap Momentum ETF | — | 183,664 | $2,306,820 | 0.60% | Long | 2026-02-28 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 238,476 | $2,286,985 | 0.01% | Long | 2026-05-31 | |
| Schwab U.S. Small-Cap ETF | — | 236,650 | $2,269,474 | 0.01% | Long | 2026-05-31 | |
| Invesco Health Care Fund | — | 184,910 | $2,070,992 | 0.18% | Long | 2026-04-30 | |
| Nomura VIP Small Cap Growth Series | — | 155,523 | $1,727,861 | 0.92% | Long | 2026-03-31 | |
| iShares U.S. Pharmaceuticals ETF | — | 139,379 | $1,548,501 | 0.15% | Long | 2026-03-31 | |
| MML Global Fund | — | 138,089 | $1,534,169 | 0.32% | Long | 2026-03-31 | |
| SFT Nomura Small Cap Growth Fund | — | 131,796 | $1,464,254 | 0.92% | Long | 2026-03-31 | |
| EQ/Invesco Global Portfolio | — | 130,953 | $1,454,888 | 0.31% | Long | 2026-03-31 | |
| Fidelity SAI Small-Mid Cap Momentum Index Fund | — | 120,654 | $1,351,325 | 0.03% | Long | 2026-04-30 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 139,582 | $1,338,591 | 0.01% | Long | 2026-05-31 | |
| iShares Micro-Cap ETF | — | 116,859 | $1,298,303 | 0.11% | Long | 2026-03-31 | |
| VANGUARD EXPLORER FUND | — | 113,018 | $1,265,802 | 0.01% | Long | 2026-04-30 | |
| Schwab Small-Cap Index Fund | — | 101,896 | $1,141,235 | 0.02% | Long | 2026-04-30 | |
| iShares Russell 2000 Growth ETF | — | 100,979 | $1,121,877 | 0.01% | Long | 2026-03-31 | |
| Fidelity Total Market Index Fund | — | 92,752 | $889,492 | 0.00% | Long | 2026-05-31 | |
| HUSSMAN STRATEGIC MARKET CYCLE FUND | — | 80,000 | $888,800 | 0.22% | Long | 2026-03-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | — | 76,746 | $852,648 | 0.00% | Long | 2026-03-31 | |
| Master Small Cap Index Series | — | 75,346 | $837,094 | 0.02% | Long | 2026-03-31 | |
| EQ/Global Equity Managed Volatility Portfolio | — | 69,145 | $768,201 | 0.05% | Long | 2026-03-31 | |
| VANGUARD U.S. MOMENTUM FACTOR ETF | — | 78,352 | $751,396 | 0.04% | Long | 2026-05-31 | |
| Virtus Biotech Etf | — | 64,997 | $727,966 | 1.23% | Long | 2026-04-30 | |
| Fidelity Series Total Market Index Fund | — | 75,754 | $726,481 | 0.00% | Long | 2026-05-31 | |
| Nuveen Small Cap Blend Index Fund | — | 55,435 | $620,872 | 0.02% | Long | 2026-04-30 | |
| Nuveen Equity Index Fund | — | 54,024 | $605,069 | 0.00% | Long | 2026-04-30 | |
| VANGUARD STRATEGIC SMALL-CAP EQUITY FUND | — | 51,893 | $576,531 | 0.02% | Long | 2026-03-31 | |
| Goldman Sachs Small Cap Value Insights Fund | — | 51,303 | $574,594 | 0.05% | Long | 2026-04-30 | |
| EQ/2000 Managed Volatility Portfolio | — | 48,736 | $541,457 | 0.02% | Long | 2026-03-31 | |
| JPMorgan Small Cap Value Fund | — | 47,636 | $529,236 | 0.05% | Long | 2026-03-31 | |
| Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF | — | 49,552 | $475,204 | 0.05% | Long | 2026-05-31 |
Showing 1–50 of 160 positions
Key facts
CIK
1783183
CUSIP
71722W107
13F (30d)
22 filings
22 filers
Visit website
Investor relations